The Value of Immunohistochemical Expression of SOX9 and CD34 in Alopecia Areata

    Heba A. S. Bazid, Alaa Marae, Bassant Farag, Rania Abdallah Abdallah
    TLDR Alopecia areata patients have lower SOX9 and CD34 levels, affecting hair growth.
    The study investigates the immunohistochemical expression of SOX9 and CD34 in patients with alopecia areata to understand their potential roles in the disease's pathogenesis. The research highlights that SOX9 and CD34 are significantly expressed in hair follicles affected by alopecia areata, suggesting their involvement in the condition. The findings indicate that these markers could be valuable in diagnosing and understanding the mechanisms of alopecia areata, potentially guiding future therapeutic strategies. The study emphasizes the importance of further research to explore the clinical applications of these markers in managing alopecia areata.
    Discuss this study in the Community →

    Research cited in this study

    26 / 26 results